NCT01266512 - Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Lung Neoplasms

Interventions

DRUG

DOCETAXEL

Pharmaceutical form: docetaxel 20mg or 80 mg concentrate for solution for infusion Route of administration: intravenous

RADIATION

Intensity Modulated Radiotherapy (IMRT)

2 Gy per fraction

DRUG

CISPLATIN

Pharmaceutical form: solution for infusion Route of administration: intravenous

Trial Locations (1)

Sanofi-Aventis Administrative Office, Hong Kong